Login to Your Account



FDA Approvals In October


Monday, November 14, 2011

Company

Drug

Indication


Amylin Pharmaceuticals Inc.

Byetta

Add-on therapy to insulin glargine, with or without metformin and/or a thiazolidinedione, in conjunction with diet and exercise for Type II diabetic adults

ApoPharma Inc.

Ferriprox

Iron overload due to blood transfusions with thalassemia

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription